Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name SUMO1P3
   Synonyms NA
   Region GRCh38_1:160317403-160317706    Sequence
   Ensembl ENSG00000235082
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colon cancer
   ICD-0-3 C18  
   Methods qPCR, Western blot
   Sample colon cancer tissues, cell lines (HT29, HCT116, SW480, SW620, and LoVo, NCM460 and HUVECs)
   Expression Pattern up-regulated
   Function Description

The upregulation of SUMO1P3 was positively correlated with the advanced histological stages, metastases, angiogenesis and poor prognosis of colon cancer patients. SUMO1P3 knockdown repressed the proliferation, migration,invasion, and pro-angiogenesis of colon cancer cells in vitro. SUMO1P3 silencing reduced the growth, liver metastasis, and vascularization of colon cancer in vivo. SUMO1P3 depletion decreased the levels of cyclin D1, Vimentin, and VEGFA while increased E-cadherin expression in xenograft tumor tissues.the patients with high levels of SUMO1P3 had shorter survival rates than those with low levels of SUMO1P3.

   Pubmed ID 29312498
   Year 2017
   Title LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis.
   External Links
   Links for  SUMO1P3 GenBank       HGNC       lncrnadb       Noncode
   Links for  colon cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.